First Name,Last Name,Full Name,Job Title,Company Name,Location,Employee Count,Phone,Industry,URL,LinkedIn URL,Facebook URL,Twitter URL,Company LinkedIn URL,Company URL,Keywords,Email 1,Email 2
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",,
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",,
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",,
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",,
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",,
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",,
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",,
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",,
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",,
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",,
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",,
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",mlandes@annexonbio.com,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jmcalpine@annexonbio.com,mcalpj@gmail.com
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jchun@annexonbio.com,justinvchun@gmail.com
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",doug@annexonbio.com,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",jchow@chimerictherapeutics.com,jenniferchowarpa@yahoo.com
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",tinawang@liontcr.com,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",ola.melin@targovax.com,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",asia.chang@freenome.com,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",roman.necina@hookipapharma.com,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",elaine.cheung@moonwalk.bio,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",achahal@biomeafusion.com,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",sarah.q@briibio.com,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",dcouto@vedantabio.com,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",sanjeev.luther@eternatx.com,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",cchee@syros.com,conleychee@hotmail.com
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ssingh@pacificbiosciences.com,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",todd.smith@jazzpharma.com,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ramon@parsebiosciences.com,ramon.m@gmail.com
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",sparthasarathy@accenttx.com,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",kristen.baugher@mirumpharma.com,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",lorna@hibio.com,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jorge@mirumpharma.com,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",ameyer@januxrx.com,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",phellsund@cybrexa.com,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",asilva@allovir.com,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",mlandes@annexonbio.com,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jmcalpine@annexonbio.com,mcalpj@gmail.com
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jchun@annexonbio.com,justinvchun@gmail.com
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",doug@annexonbio.com,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",jchow@chimerictherapeutics.com,jenniferchowarpa@yahoo.com
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",tinawang@liontcr.com,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",ola.melin@targovax.com,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",asia.chang@freenome.com,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",roman.necina@hookipapharma.com,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",elaine.cheung@moonwalk.bio,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",achahal@biomeafusion.com,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",sarah.q@briibio.com,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",dcouto@vedantabio.com,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",sanjeev.luther@eternatx.com,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",cchee@syros.com,conleychee@hotmail.com
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ssingh@pacificbiosciences.com,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",todd.smith@jazzpharma.com,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ramon@parsebiosciences.com,ramon.m@gmail.com
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",sparthasarathy@accenttx.com,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",kristen.baugher@mirumpharma.com,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",lorna@hibio.com,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jorge@mirumpharma.com,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",ameyer@januxrx.com,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",phellsund@cybrexa.com,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",asilva@allovir.com,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",mlandes@annexonbio.com,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jmcalpine@annexonbio.com,mcalpj@gmail.com
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jchun@annexonbio.com,justinvchun@gmail.com
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",doug@annexonbio.com,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",jchow@chimerictherapeutics.com,jenniferchowarpa@yahoo.com
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",tinawang@liontcr.com,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",ola.melin@targovax.com,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",asia.chang@freenome.com,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",roman.necina@hookipapharma.com,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",elaine.cheung@moonwalk.bio,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",achahal@biomeafusion.com,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",sarah.q@briibio.com,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",dcouto@vedantabio.com,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",sanjeev.luther@eternatx.com,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",cchee@syros.com,conleychee@hotmail.com
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ssingh@pacificbiosciences.com,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",todd.smith@jazzpharma.com,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ramon@parsebiosciences.com,ramon.m@gmail.com
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",sparthasarathy@accenttx.com,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",kristen.baugher@mirumpharma.com,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",lorna@hibio.com,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jorge@mirumpharma.com,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",ameyer@januxrx.com,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",phellsund@cybrexa.com,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",asilva@allovir.com,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",mlandes@annexonbio.com,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jmcalpine@annexonbio.com,mcalpj@gmail.com
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jchun@annexonbio.com,justinvchun@gmail.com
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",doug@annexonbio.com,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",jchow@chimerictherapeutics.com,jenniferchowarpa@yahoo.com
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",tinawang@liontcr.com,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",ola.melin@targovax.com,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",asia.chang@freenome.com,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",roman.necina@hookipapharma.com,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",elaine.cheung@moonwalk.bio,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",achahal@biomeafusion.com,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",sarah.q@briibio.com,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",dcouto@vedantabio.com,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",sanjeev.luther@eternatx.com,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",cchee@syros.com,conleychee@hotmail.com
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ssingh@pacificbiosciences.com,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",todd.smith@jazzpharma.com,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ramon@parsebiosciences.com,ramon.m@gmail.com
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",sparthasarathy@accenttx.com,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",kristen.baugher@mirumpharma.com,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",lorna@hibio.com,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jorge@mirumpharma.com,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",ameyer@januxrx.com,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",phellsund@cybrexa.com,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",asilva@allovir.com,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",mlandes@annexonbio.com,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jmcalpine@annexonbio.com,mcalpj@gmail.com
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jchun@annexonbio.com,justinvchun@gmail.com
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",doug@annexonbio.com,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",jchow@chimerictherapeutics.com,jenniferchowarpa@yahoo.com
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",tinawang@liontcr.com,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",ola.melin@targovax.com,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",asia.chang@freenome.com,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",roman.necina@hookipapharma.com,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",elaine.cheung@moonwalk.bio,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",achahal@biomeafusion.com,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",sarah.q@briibio.com,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",dcouto@vedantabio.com,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",sanjeev.luther@eternatx.com,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",cchee@syros.com,conleychee@hotmail.com
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ssingh@pacificbiosciences.com,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",todd.smith@jazzpharma.com,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ramon@parsebiosciences.com,ramon.m@gmail.com
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",sparthasarathy@accenttx.com,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",kristen.baugher@mirumpharma.com,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",lorna@hibio.com,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jorge@mirumpharma.com,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",ameyer@januxrx.com,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",phellsund@cybrexa.com,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",asilva@allovir.com,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",mlandes@annexonbio.com,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jmcalpine@annexonbio.com,mcalpj@gmail.com
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jchun@annexonbio.com,justinvchun@gmail.com
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",doug@annexonbio.com,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",jchow@chimerictherapeutics.com,jenniferchowarpa@yahoo.com
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",tinawang@liontcr.com,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",ola.melin@targovax.com,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",asia.chang@freenome.com,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",roman.necina@hookipapharma.com,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",elaine.cheung@moonwalk.bio,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",achahal@biomeafusion.com,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",sarah.q@briibio.com,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",dcouto@vedantabio.com,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",sanjeev.luther@eternatx.com,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",cchee@syros.com,conleychee@hotmail.com
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ssingh@pacificbiosciences.com,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",todd.smith@jazzpharma.com,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ramon@parsebiosciences.com,ramon.m@gmail.com
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",sparthasarathy@accenttx.com,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",kristen.baugher@mirumpharma.com,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",lorna@hibio.com,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jorge@mirumpharma.com,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",ameyer@januxrx.com,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",phellsund@cybrexa.com,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",asilva@allovir.com,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",mlandes@annexonbio.com,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jmcalpine@annexonbio.com,mcalpj@gmail.com
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jchun@annexonbio.com,justinvchun@gmail.com
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",doug@annexonbio.com,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",jchow@chimerictherapeutics.com,jenniferchowarpa@yahoo.com
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",tinawang@liontcr.com,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",ola.melin@targovax.com,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",asia.chang@freenome.com,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",roman.necina@hookipapharma.com,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",elaine.cheung@moonwalk.bio,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",achahal@biomeafusion.com,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",sarah.q@briibio.com,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",dcouto@vedantabio.com,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",sanjeev.luther@eternatx.com,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",cchee@syros.com,conleychee@hotmail.com
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ssingh@pacificbiosciences.com,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",todd.smith@jazzpharma.com,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ramon@parsebiosciences.com,ramon.m@gmail.com
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",sparthasarathy@accenttx.com,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",kristen.baugher@mirumpharma.com,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",lorna@hibio.com,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jorge@mirumpharma.com,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",ameyer@januxrx.com,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",phellsund@cybrexa.com,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",asilva@allovir.com,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",mlandes@annexonbio.com,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jmcalpine@annexonbio.com,mcalpj@gmail.com
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jchun@annexonbio.com,justinvchun@gmail.com
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",doug@annexonbio.com,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",jchow@chimerictherapeutics.com,jenniferchowarpa@yahoo.com
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",tinawang@liontcr.com,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",ola.melin@targovax.com,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",asia.chang@freenome.com,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",roman.necina@hookipapharma.com,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",elaine.cheung@moonwalk.bio,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",achahal@biomeafusion.com,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",sarah.q@briibio.com,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",dcouto@vedantabio.com,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",sanjeev.luther@eternatx.com,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",cchee@syros.com,conleychee@hotmail.com
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ssingh@pacificbiosciences.com,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","160","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",todd.smith@jazzpharma.com,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ramon@parsebiosciences.com,ramon.m@gmail.com
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","53","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",sparthasarathy@accenttx.com,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",kristen.baugher@mirumpharma.com,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","50","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",lorna@hibio.com,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jorge@mirumpharma.com,
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",ameyer@januxrx.com,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",phellsund@cybrexa.com,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","88","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",asilva@allovir.com,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",mlandes@annexonbio.com,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jmcalpine@annexonbio.com,mcalpj@gmail.com
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jchun@annexonbio.com,justinvchun@gmail.com
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",doug@annexonbio.com,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",jchow@chimerictherapeutics.com,jenniferchowarpa@yahoo.com
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",tinawang@liontcr.com,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",ola.melin@targovax.com,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",asia.chang@freenome.com,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",roman.necina@hookipapharma.com,
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",elaine.cheung@moonwalk.bio,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",achahal@biomeafusion.com,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","110","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",sarah.q@briibio.com,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",dcouto@vedantabio.com,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",sanjeev.luther@eternatx.com,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",cchee@syros.com,conleychee@hotmail.com